D'Arienzo, V.* ; Magri, A.* ; Harris, J.M.* ; Wing, P.A.C.* ; Ko, C. ; Rubio, C.O.* ; Revill, P.A.* ; Protzer, U. ; Balfe, P.* ; McKeating, J.A.*
A PCR assay to quantify patterns of HBV transcription.
J. Gen. Virol. 102:001373 (2019)
Hepatitis B virus (HBV) is the prototype member of the family Hepadnaviridae and replicates via episomal copies of a covalently closed circular DNA (cccDNA) genome of approximately 3.2 kb. The chromatinization of this small viral genome, with overlapping open reading frames and regulatory elements, suggests an important role for epigenetic pathways to regulate HBV transcription. However, the host pathways that regulate HBV transcription and the temporal nature of promoter usage in infected cells are not well understood, in part due to the compact genome structure and overlapping open reading frames. To address this we developed a simple and cost-effective PCR assay to quantify the major viral RNAs and validated this technique using current state-of-art de novo HBV infection model systems. Our PCR method is three orders of magnitude more sensitive than Northern blot and requires relatively small amounts of starting material, making this an attractive tool for assessing HBV transcription.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Hepatitis B Virus ; Rna ; Transcription
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
0022-1317
e-ISSN
1465-2099
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 102,
Heft: 3,
Seiten: ,
Artikelnummer: 001373
Supplement: ,
Reihe
Verlag
Society for General Microbiology
Verlagsort
Charles Darwin House, 12 Roger St, London Wc1n 2ju, Erks, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Immune Response and Infection
PSP-Element(e)
G-502700-003
Förderungen
Wellcome Trust
MRC
EU 2020 Research and Innovation Programme Consortia HEP-CAR
Copyright
Erfassungsdatum
2020-01-15